← Back to Dr Reddys Laboratories Ltd Overview
📊Financials📈PE Ratio🥧Shareholding💰Dividend📋Quarterly⚖️Balance Sheet💹P&L🌊Cash Flow
DRREDDYPharmaceuticals

Dr Reddys Laboratories Ltd — Financial Ratios & Key Metrics

₹1254.90
-1.46%
P/E Ratio18.23xIndustry: 31.77x
ROE17.96%Return on equity
ROCE22.69%Return on capital
Debt/Equity0.16Low debt
💎

Valuation & Profitability

P/E Ratio
18.23x
Industry Average P/E
31.77x
Dividend Yield
0.63%
Market Cap
₹1.05L (Cr)
Sales Growth 5Y
13.26%
Profit Growth 5Y
22.28%
EPS Growth 5Y
22.17%
OPM 5Y Avg
24.30%
📉

Price Returns

1 Month
+5.22%
3 Months
+0.51%
6 Months
+0.66%
1 Year
+4.81%
52W Low
₹1020
Current
₹1255
52W High
₹1380
65% of 52-week range — Mid range
🔬

Technical Indicators

46RSI 14
Neutral
Momentum is balanced — neither overbought nor oversold.
SMA 50
₹1261
▼ Price below SMA 50 — Bearish
SMA 200
₹1264
▼ Long-term downtrend
Volume Signal
132% of avg
Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Dr Reddys Laboratories Ltd

OverviewFinancialsPE HistoryShareholdingQuarterlyBalance SheetP&LCash FlowPharmaceuticals StocksScreener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.